Different domains used to assess quality of life in children with Rett syndrome also may be useful for adults, a…
Articles by Patricia Inácio, PhD
The first patient has been dosed in Anavex Life Sciences’ AVATAR Phase 2 trial, taking place in Australia, and evaluating the…
A new Phase 2 clinical study to evaluate the investigational therapy candidate Anavex 2-73 for the treatment of Rett syndrome…
Mutations in the MECP2 gene, the underlying cause of Rett syndrome, affect genes that regulate several cellular functions, including inflammation, cellular stress…
The first patient has been dosed in Anavex Life Sciences’ Phase 2 trial evaluating Anavex 2-73 for the treatment of Rett syndrome.
Three-dimensional microbrains built in the lab using stem cells from Rett syndrome patients can become a new model to study…
Patient enrollment is now complete for the pivotal STARS study investigating the safety, tolerability, and effectiveness of sarizotan in…